Other languages Physiomics Plc

Equities

Delayed London S.E. Other stock markets 04:09:38 2024-04-30 am EDT			5-day change	1st Jan Change
1.549 ^GBX	+3.27%		-0.06%	-3.19%

Mar. 18	Transcript : Physiomics Plc, H1 2024 Earnings Call, Mar 18, 2024
Mar. 18	Physiomics celebrates "substantial" contract with old client	AN

Physiomics celebrates "substantial" contract with old client	Mar. 18
Physiomics Wins DNA-related Modeling Contract with Large Pharmaceutical Company	Mar. 18
Physiomics plc Wins Contract by an Existing Pharma Client	Mar. 18
Physiomics reports higher interim revenue; loss narrows	Mar. 07
Physiomics Plc Reports Earnings Results for the Half Year Ended December 31, 2023	Mar. 07
Physiomics celebrates contract award for cancer therapy insect model	Feb. 19
The University of Sheffield Selects Physiomics plc to Support a Grant funded Project Focused on an Insect (Fruit Fly) Model of Cancer Treatment	Feb. 19
Physiomics wins deal to support client's oncology assets	Feb. 05
Physiomics plc Announces Contract Award	Feb. 05
Physiomics appoints COO Sargent as new CEO; completes restructuring	Jan. 22
Physiomics Names CEO as Chairman	Jan. 22
Physiomics plc Announces Chief Executive Officer Changes	Jan. 22
Physiomics plc Announces Executive Changes	Jan. 22
Physiomics Secures Grant to Advance Personalized Chemotherapy Tool in UK	Nov. 10
Physiomics gets UK government grant for oncology dosing tool project	Nov. 10
Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics	23-10-03
Physiomics shares drop as annual loss widens; revenue falls	23-09-28
Stocks stay downbeat; Digital 9 plunges 32%	23-09-28
AIM WINNERS & LOSERS: Bradda shares surge on updated resource estimate	23-09-28
Physiomics Plc Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-28

No results for this search